SNDL books record free cash flow while it reviews its grow business
Cannabis retail held up; production shrank after the company quit unprofitable domestic flower and took a C$52 million write-down.
Produced by MetaFlora's AI newsroom from the sources listed at the end of this article. How we report
SNDL reported third-quarter revenue of C$238.0 million on 27 October, 2.5% lower than a year earlier, and an operating loss of C$48.3 million, up from C$11.1 million. Almost all of the loss came from a C$52.0 million noncash impairment of goodwill and intangible assets in its cannabis operations segment. Stripping out that and other items, adjusted operating income was C$5.2 million, against a C$9.5 million loss a year ago.
Cannabis retail revenue edged up 0.7% at a record margin, while cannabis operations revenue fell 27.7%. Free cash flow reached a quarterly record of C$20.0 million, and the company has opened a strategic review of its production business that could include selling assets.
Four businesses, one problem child
SNDL reports four segments, and three of them did their job. Liquor retail, the largest, brought in C$134.8 million, down 3.3%, with same-store sales off 6.0%. Its gross margin still reached a record 27.0%, and the segment earned C$6.0 million in operating income. On the call, management said private-label products outgrew national brands by 8.5 percentage points. The company runs 165 liquor stores, mainly in Alberta, under the Ace Liquor, Wine and Beyond and Liquor Depot banners.
Cannabis retail, which includes 133 Value Buds stores and 60 Spiritleaf locations, posted record revenue of C$85.6 million and a record 27.0% gross margin, with operating income up 3.9% to C$5.2 million. Same-store sales still fell 3.8%, which SNDL put down to shrinking markets in Ontario and Alberta. The investments segment, built around its stake in SunStream Bancorp, contributed C$7.9 million of operating income.
Cannabis operations is where the quarter went wrong. Revenue fell to C$27.0 million, gross profit swung to a loss of C$1.6 million, and the gross margin was negative 6.0%. Including the impairment, the segment lost C$64.7 million at the operating line. SNDL said the revenue drop mainly reflects its exit from domestic dried flower, and it booked about C$6 million of other charges, mostly inventory adjustments and cost variances on its Jeeter products.
Why the production arm is under review
SNDL said cannabis operations had underperformed, hurt by inventory problems earlier in the year, and that it will weigh options ranging from asset sales to broader productivity programs. It gave no timetable and named no advisers. It has already cut more than 30% of the workforce at its Kelowna facility and expects savings to show from the fourth quarter.
Chief executive Zach George told analysts the segment remains below expectations and argued that indoor growing does not suit where Canada's flower market now sits, given the cost edge of large hybrid greenhouse producers. Chief financial officer Alberto Paredero-Quiros was blunter about the review: "All options are valid." Management also said it expects EU GMP certification for its Atholville, New Brunswick site, which it says could lower processing costs and improve export pricing.
SNDL is quietly turning into a retailer and an investor. The question the review must answer is whether owning cultivation still adds anything to that model.
A record cash quarter, with an asterisk
Free cash flow of C$20.0 million beat last year's C$16.7 million, but C$10.6 million came from the first unwinding of a captive insurance arrangement, and management flagged about C$8 million more to come in the fourth quarter. Over nine months, free cash flow was C$5.7 million, below the C$7.7 million of a year earlier. Adjusted EBITDA fell 12.5% to C$15.8 million, and the consolidated gross margin slipped two points to 24.3%. Net loss was C$50.8 million. As Cannatech Today put it, the record cash quarter arrived next to a substantial operating loss.
Balance sheet and buybacks
SNDL ended September with C$132.5 million in cash, down from C$252.2 million at the end of 2025 as money moved into U.S. investments, and no debt. Including marketable securities and investments, unrestricted holdings stood at C$617.8 million. Shareholders' equity was C$1.0 billion, and goodwill fell to C$75.2 million from C$124.2 million.
The company bought back 5.4 million shares for C$10.0 million in the quarter, at an average of US$1.31, and C$43.1 million over nine months. It has proposed a substantial issuer bid of up to C$50 million at no more than C$1.92 (US$1.35) a share, still subject to board approval, which could retire more than 10% of the remaining stock if fully taken up. The current buyback program expires on 20 November, and management expects to renew it.
Ontario and the U.S. bet
Two other moves could reshape the reported numbers. A proposed settlement with Ontario's regulator, the AGCO, carries a C$200,000 penalty and would let the Value Buds franchise network resume growth in the province after more than a year on hold. The Ontario stores would then be deconsolidated, which management said would cut reported revenue by about C$105 million but operating income by only about C$2 million.
In the U.S., SNDL put C$60.8 million into equity-accounted investees during the quarter. After a restructuring of U.S. cannabis company Parallel closed on 27 July, SNDL's indirect stake in it rose to about 92%, and SunStream raised its share of Parallel's takeback debt to 69.4%. George said SNDL will not wait for federal action before focusing on what it can control.
What to watch
The buyback program lapses on 20 November, so expect news on its renewal and on board approval of the issuer bid. Beyond that, watch for the outcome of the cannabis operations review, the Atholville GMP certificate, final paperwork on the Ontario settlement, and whether Kelowna savings show up in fourth-quarter margins.
Sources
This article summarises and links the original reporting. Spotted an error? Email support@metaflora.xyz or message @MetaFloraLabs on X.
